New Risk • 23h
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$99.6m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.9% per year over the past 5 years. Minor Risk Market cap is less than US$100m (US$99.6m market cap). Announcement • Jun 29
Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell Microcap Growth Benchmark Index Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell Microcap Growth Benchmark Index Board Change • Jun 18
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. Independent Director Janie Goddard was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jun 03
Ultralife Corporation, Annual General Meeting, Jul 22, 2026 Ultralife Corporation, Annual General Meeting, Jul 22, 2026. Location: 2020 convention center concourse, atlanta, ga, 30337, United States Announcement • May 02
Ultralife Corporation to Report Q1, 2026 Results on May 08, 2026 Ultralife Corporation announced that they will report Q1, 2026 results at 9:30 AM, US Eastern Standard Time on May 08, 2026 Announcement • Mar 18
Ultralife Corporation announced delayed annual 10-K filing On 03/17/2026, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Announcement • Mar 10
Ultralife Corporation Reports Unaudited Impairment Results for the Fourth Quarter Ended December 31, 2025 Ultralife Corporation reported unaudited impairment results for the fourth quarter ended December 31, 2025. For the period, the company reported intangible asset impairment of $12,181,000. In the quarter of 2025, the company decided to undergo a comprehensive rebranding initiative that consolidated all sub-brands under a singular, unified master brand – Ultralife. To this end, the Accutronics, Southwest Electronic Energy, Excell Battery, McDowell Research and AMTI brands will no longer be used. The Electrochem brand will remain in use, but as a product brand on select primary cells. As a result of the rebranding initiative, the company recorded a $12.2 million non-cash charge to reduce the value of the company’s tradename and trademark intangible assets. Announcement • Mar 06
Ultralife Corporation to Report Q4, 2025 Results on Mar 10, 2026 Ultralife Corporation announced that they will report Q4, 2025 results Pre-Market on Mar 10, 2026 Announcement • Nov 14
Ultralife Corporation to Report Q3, 2025 Results on Nov 18, 2025 Ultralife Corporation announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 18, 2025 Announcement • Nov 08
Ultralife Corporation announced delayed 10-Q filing On 11/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Announcement • Jul 29
Ultralife Corporation to Report Q2, 2025 Results on Aug 07, 2025 Ultralife Corporation announced that they will report Q2, 2025 results Pre-Market on Aug 07, 2025 Announcement • May 29
Ultralife Corporation, Annual General Meeting, Jul 16, 2025 Ultralife Corporation, Annual General Meeting, Jul 16, 2025. Location: atlanta airport marriott gateway, 2020 convention center concourse, ga 30337, atlanta United States Announcement • Apr 29
Ultralife Corporation to Report Q1, 2025 Results on May 09, 2025 Ultralife Corporation announced that they will report Q1, 2025 results Pre-Market on May 09, 2025 Announcement • Mar 09
Ultralife Corporation announced delayed annual 10-K filing On 03/07/2025, Ultralife Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Announcement • Feb 26
Ultralife Corporation to Report Q4, 2024 Results on Mar 11, 2025 Ultralife Corporation announced that they will report Q4, 2024 results Pre-Market on Mar 11, 2025 Announcement • Jan 06
Ultralife Corporation Announces the Appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, Effective January 6, 2025 Ultralife Corporation announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife’s products and solutions meet the evolving needs of customers. Jeff brings over two decades of experience in B2B marketing, including genomics, agriculture, heavy equipment, energy and industrial computing. In his new role, James will focus on expanding reach into both existing and new markets and applications, and on aligning the efforts of global sales and business development teams in pursuing opportunities that maximize revenue, build strategic partnerships, and strengthen presence in competitive markets. He brings over thirty-seven years of experience in the battery and power industry, with a career that spans all major segments of the industry, including cell manufacturing, pack manufacturing, charger development, and work with representative organizations supporting battery and power solutions. Announcement • Oct 24
Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024 Ultralife Corporation announced that they will report Q3, 2024 results Pre-Market on Nov 08, 2024 Announcement • Oct 01
Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million. Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million on September 30, 2024. A cash consideration of $50 million will be paid by Ultralife Corporation. As part of consideration, $50 million is paid towards common equity of Electrochem Solutions, Inc. Ultralife expects to finance the transaction through its primary lender.
The expected completion of the transaction is by the end of October 2024. Announcement • Jul 12
Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024 Ultralife Corporation announced that they will report Q2, 2024 results Pre-Market on Jul 25, 2024 Announcement • May 31
Ultralife Corporation, Annual General Meeting, Jul 16, 2024 Ultralife Corporation, Annual General Meeting, Jul 16, 2024. Location: eastern time at the sheraton charlotte, airport hotel located at 3315, scott futrell drive, nc 28202, charlotte United States Valuation Update With 7 Day Price Move • May 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to US$12.56, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 60% over the past three years. Price Target Changed • Apr 28
Price target decreased by 7.7% to US$12.00 Down from US$13.00, the current price target is provided by 1 analyst. New target price is 5.4% above last closing price of US$11.39. Stock is up 171% over the past year. The company is forecast to post earnings per share of US$0.61 for next year compared to US$0.44 last year. Reported Earnings • Apr 26
First quarter 2024 earnings: EPS and revenues exceed analyst expectations First quarter 2024 results: EPS: US$0.18 (up from US$0.021 loss in 1Q 2023). Revenue: US$41.9m (up 31% from 1Q 2023). Net income: US$2.89m (up US$3.24m from 1Q 2023). Profit margin: 6.9% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Revenue exceeded analyst estimates by 10%. Earnings per share (EPS) also surpassed analyst estimates by 100%. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Announcement • Apr 12
Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024 Ultralife Corporation announced that they will report Q1, 2024 results Pre-Market on Apr 25, 2024 Reported Earnings • Mar 23
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Reported Earnings • Feb 18
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Full year 2023 results: EPS: US$0.44 (up from US$0.007 loss in FY 2022). Revenue: US$158.6m (up 20% from FY 2022). Net income: US$7.20m (up US$7.32m from FY 2022). Profit margin: 4.5% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 15
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to US$7.90, the stock trades at a trailing P/E ratio of 31.5x. Average trailing P/E is 19x in the Electrical industry in the US. Total returns to shareholders of 7.5% over the past three years. New Risk • Feb 09
New major risk - Revenue and earnings growth Earnings have declined by 59% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Announcement • Jan 30
Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024 Ultralife Corporation announced that they will report Q4, 2023 results Pre-Market on Feb 15, 2024 Recent Insider Transactions • Dec 11
Independent Chairman recently bought US$111k worth of stock On the 8th of December, Bradford Whitmore bought around 16k shares on-market at roughly US$6.99 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$181k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares. Recent Insider Transactions • Dec 01
Independent Chairman recently bought US$181k worth of stock On the 29th of November, Bradford Whitmore bought around 25k shares on-market at roughly US$7.20 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.6m worth in shares. Recent Insider Transactions • Nov 03
Independent Chairman recently bought US$99k worth of stock On the 1st of November, Bradford Whitmore bought around 14k shares on-market at roughly US$7.14 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$112k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares. Valuation Update With 7 Day Price Move • Nov 02
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to US$7.44, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Electrical industry in the US. Total returns to shareholders of 45% over the past three years. Reported Earnings • Oct 26
Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations Third quarter 2023 results: EPS: US$0.082 (up from US$0.015 loss in 3Q 2022). Revenue: US$39.5m (up 19% from 3Q 2022). Net income: US$1.33m (up US$1.57m from 3Q 2022). Profit margin: 3.4% (up from net loss in 3Q 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 9.9% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Electrical industry in the US. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. Announcement • Oct 13
Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023 Ultralife Corporation announced that they will report Q3, 2023 results Pre-Market on Oct 26, 2023 Valuation Update With 7 Day Price Move • Oct 02
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to US$11.37, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 21x in the Electrical industry in the US. Total returns to shareholders of 88% over the past three years. Recent Insider Transactions • Sep 18
Independent Chairman recently bought US$112k worth of stock On the 15th of September, Bradford Whitmore bought around 11k shares on-market at roughly US$10.15 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares. Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to US$10.43, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 20x in the Electrical industry in the US. Total returns to shareholders of 64% over the past three years. Major Estimate Revision • Aug 09
Consensus revenue estimates increase by 12% The consensus outlook for revenues in fiscal year 2023 has improved. 2023 revenue forecast increased from US$136.8m to US$153.1m. EPS estimate increased from US$0.21 to US$0.35 per share. Net income forecast to grow 196% next year vs 16% growth forecast for Electrical industry in the US. Consensus price target of US$12.00 unchanged from last update. Share price was steady at US$8.54 over the past week. New Risk • Jul 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 16% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. This is currently the only risk that has been identified for the company. Reported Earnings • Jul 28
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Second quarter 2023 results: EPS: US$0.21 (up from US$0.032 in 2Q 2022). Revenue: US$42.7m (up 33% from 2Q 2022). Net income: US$3.34m (up US$2.83m from 2Q 2022). Profit margin: 7.8% (up from 1.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 33%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.2% p.a. on average during the next 2 years, compared to a 9.0% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Announcement • Jul 14
Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023 Ultralife Corporation announced that they will report Q2, 2023 results Pre-Market on Jul 27, 2023 Recent Insider Transactions • Jun 18
Independent Chairman recently bought US$398k worth of stock On the 14th of June, Bradford Whitmore bought around 81k shares on-market at roughly US$4.94 per share. This transaction amounted to 1.5% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.9m worth in shares. Recent Insider Transactions • Jun 04
Independent Chairman recently bought US$146k worth of stock On the 1st of June, Bradford Whitmore bought around 34k shares on-market at roughly US$4.31 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares. Announcement • May 31
Ultralife Corporation, Annual General Meeting, Jul 19, 2023 Ultralife Corporation, Annual General Meeting, Jul 19, 2023, at 09:00 US Eastern Standard Time. Location: Ultralife Corporation Headquarters located at 2000 Technology Parkway, Newark New York United States Agenda: To consider Election of directors; to consider ratification of the selection of Freed Maxick CPAs, P.C. as company's independent registered public accounting firm for the fiscal year ending December 31, 2023; to consider and vote on a non-binding advisory resolution on executive compensation; to vote on a non-binding advisory resolution on the frequency of future advisory votes on executive compensation; and to consider other matters. Recent Insider Transactions • May 14
Independent Chairman recently bought US$117k worth of stock On the 11th of May, Bradford Whitmore bought around 29k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth US$122k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.5m worth in shares. Reported Earnings • Apr 06
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Mar 19
Independent Chairman recently bought US$122k worth of stock On the 13th of March, Bradford Whitmore bought around 30k shares on-market at roughly US$4.06 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares. Reported Earnings • Mar 03
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Full year 2022 results: US$0.007 loss per share (improved from US$0.015 loss in FY 2021). Revenue: US$131.8m (up 34% from FY 2021). Net loss: US$119.0k (loss narrowed 49% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Dec 12
Independent Chairman recently bought US$279k worth of stock On the 8th of December, Bradford Whitmore bought around 69k shares on-market at roughly US$4.03 per share. This transaction amounted to 1.3% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.7m worth in shares. Price Target Changed • Nov 17
Price target increased to US$12.00 Up from US$4.50, the current price target is provided by 1 analyst. New target price is 158% above last closing price of US$4.66. Stock is down 23% over the past year. The company is forecast to post earnings per share of US$0.17 next year compared to a net loss per share of US$0.015 last year. Board Change • Nov 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 27
Third quarter 2022 earnings: EPS misses analyst expectations Third quarter 2022 results: US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021). Revenue: US$33.2m (up 53% from 3Q 2021). Net loss: US$239.0k (loss narrowed 59% from 3Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates. Revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Aug 21
Independent Chairman recently bought US$158k worth of stock On the 18th of August, Bradford Whitmore bought around 34k shares on-market at roughly US$4.62 per share. In the last 3 months, they made an even bigger purchase worth US$467k. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.4m worth in shares. Recent Insider Transactions • Aug 06
Independent Chairman recently bought US$467k worth of stock On the 4th of August, Bradford Whitmore bought around 100k shares on-market at roughly US$4.67 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$1.2m worth in shares. Reported Earnings • Jul 28
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Second quarter 2022 results: EPS: US$0.032 (down from US$0.051 in 2Q 2021). Revenue: US$32.1m (up 20% from 2Q 2021). Net income: US$512.0k (down 37% from 2Q 2021). Profit margin: 1.6% (down from 3.0% in 2Q 2021). Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) also surpassed analyst estimates by 200%. Over the next year, revenue is forecast to grow 24%, compared to a 26% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. Recent Insider Transactions • Jun 11
Independent Chairman recently bought US$219k worth of stock On the 8th of June, Bradford Whitmore bought around 43k shares on-market at roughly US$5.10 per share. This was the largest purchase by an insider in the last 3 months. Bradford has been a buyer over the last 12 months, purchasing a net total of US$960k worth in shares. Reported Earnings • Apr 29
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: US$0.01 loss per share (down from US$0.042 profit in 1Q 2021). Revenue: US$30.4m (up 17% from 1Q 2021). Net loss: US$168.0k (down 125% from profit in 1Q 2021). Revenue exceeded analyst estimates by 19%. Earnings per share (EPS) also surpassed analyst estimates by 83%. Over the next year, revenue is forecast to grow 24%, compared to a 18% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CEO, President & Director Mike Popielec was the last director to join the board, commencing their role in 2010. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 11
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: US$0.015 loss per share (down from US$0.33 profit in FY 2020). Revenue: US$98.3m (down 8.8% from FY 2020). Net loss: US$234.0k (down 105% from profit in FY 2020). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates. Over the next year, revenue is forecast to grow 26%, compared to a 21% growth forecast for the industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance. 
